PLSH Stock Overview
Operates as a holding company, develops, manufactures, research, produces, and distributes hemp-derived cannabinoid, functional mushroom, Kratom, plant-based ingredients, and nutraceutical products for consumers and pets. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Panacea Life Sciences Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.061 |
| 52 Week High | US$0.35 |
| 52 Week Low | US$0.038 |
| Beta | 2.95 |
| 1 Month Change | -39.00% |
| 3 Month Change | -52.60% |
| 1 Year Change | -69.50% |
| 3 Year Change | -93.05% |
| 5 Year Change | n/a |
| Change since IPO | -98.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| PLSH | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -32.2% | -0.3% | -2.7% |
| 1Y | -69.5% | 7.9% | 23.4% |
Return vs Industry: PLSH underperformed the US Pharmaceuticals industry which returned 7.9% over the past year.
Return vs Market: PLSH underperformed the US Market which returned 23.4% over the past year.
Price Volatility
| PLSH volatility | |
|---|---|
| PLSH Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: PLSH's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine PLSH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 40 | Leslie Buttorff | www.panacealife.com |
Panacea Life Sciences Holdings, Inc., operates as a holding company, develops, manufactures, research, produces, and distributes hemp-derived cannabinoid, functional mushroom, Kratom, plant-based ingredients, and nutraceutical products for consumers and pets. The company also involved in the white label and contract manufacturing sales to other hemp companies, raw material sales, and tolling arrangements. In addition, it offers natural remedies under the PANA Health, PANA Beauty, PANA Pet, PANA Sport, PANA Pure, and PANA Life brand name.
Panacea Life Sciences Holdings, Inc. Fundamentals Summary
| PLSH fundamental statistics | |
|---|---|
| Market cap | US$1.27m |
| Earnings (TTM) | -US$7.67m |
| Revenue (TTM) | US$2.76m |
0.5x
P/S Ratio-0.2x
P/E RatioIs PLSH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PLSH income statement (TTM) | |
|---|---|
| Revenue | US$2.76m |
| Cost of Revenue | US$6.63m |
| Gross Profit | -US$3.87m |
| Other Expenses | US$3.80m |
| Earnings | -US$7.67m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.37 |
| Gross Margin | -139.86% |
| Net Profit Margin | -277.51% |
| Debt/Equity Ratio | -163.5% |
How did PLSH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 23:55 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Panacea Life Sciences Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|